BSE Live
Jan 23, 16:01Prev. Close
68.50
Open Price
68.50
Bid Price (Qty.)
66.00 (70)
Offer Price (Qty.)
75.64 (45)
NSE Live
Jan 23, 15:42Prev. Close
68.45
Open Price
68.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
66.40 (40)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 2.02 | 3.68 | |
| Diluted EPS (Rs.) | 2.02 | 3.68 | |
| Cash EPS (Rs.) | 3.71 | 5.37 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 28.84 | 27.32 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 28.84 | 27.32 | |
| Dividend / Share(Rs.) | 0.75 | 1.50 | |
| Revenue from Operations/Share (Rs.) | 82.73 | 99.01 | |
| PBDIT/Share (Rs.) | 8.43 | 10.35 | |
| PBIT/Share (Rs.) | 7.05 | 9.01 | |
| PBT/Share (Rs.) | 3.61 | 5.27 | |
| Net Profit/Share (Rs.) | 2.02 | 3.68 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 10.18 | 10.45 | |
| PBIT Margin (%) | 8.52 | 9.09 | |
| PBT Margin (%) | 4.36 | 5.32 | |
| Net Profit Margin (%) | 2.44 | 3.71 | |
| Return on Networth / Equity (%) | 7.00 | 13.46 | |
| Return on Capital Employed (%) | 3.85 | 7.91 | |
| Return on Assets (%) | 1.96 | 3.55 | |
| Total Debt/Equity (X) | 1.51 | 1.30 | |
| Asset Turnover Ratio (%) | 80.55 | 95.63 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.32 | 1.20 | |
| Quick Ratio (X) | 0.61 | 0.60 | |
| Inventory Turnover Ratio (X) | 2.32 | 2.89 | |
| Dividend Payout Ratio (NP) (%) | 59.39 | 40.76 | |
| Dividend Payout Ratio (CP) (%) | 32.37 | 27.92 | |
| Earnings Retention Ratio (%) | 40.61 | 59.24 | |
| Cash Earnings Retention Ratio (%) | 67.63 | 72.08 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 62.80 | 44.85 | |
| EV/Net Operating Revenue (X) | 1.16 | 0.79 | |
| EV/EBITDA (X) | 11.41 | 7.56 | |
| MarketCap/Net Operating Revenue (X) | 0.63 | 0.36 | |
| Retention Ratios (%) | 40.60 | 59.23 | |
| Price/BV (X) | 1.79 | 1.32 | |
| Price/Net Operating Revenue | 0.63 | 0.36 | |
| Earnings Yield | 0.04 | 0.10 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y